Changes of the redox potential of NK-Ly tumour cells after DBD (1,6-dibromo-1,6-dideoxy-dulcitol) treatment.
D000814:Aniline Compounds; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000378:metabolism*; D002951:Citrates; D004376:Galactitol / Q000627:therapeutic use; D008345:Manganese; D051379:Mice; D010084:Oxidation-Reduction; D013402:Sugar Alcohols / Q000627:therapeutic use*
D000814:Aniline Compounds; D002951:Citrates; D013402:Sugar Alcohols; D004376:Galactitol; D008345:Manganese